Symbiotec Pharmalab raises Rs 526 cr from anchor investors; IPO opens on Aug 24
The anchor placement attracted mutual funds, insurers and foreign investors, setting the stage for the pharmaceutical company’s public market debut
We haven't written up this one. Hindu BusinessLine has the full story — the link below goes straight to it.